SEC Filing Details
Document Details
Form
Filing Date
Aug 13, 2019
Document Date
Aug 13, 2019
Form Description
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Group
Current Reports
Company
VBL Therapeutics
Issuer
Vascular Biogenics Ltd.
